NAD Atlas
Explore by ingredientNAD+NRNMNCompare providers

LumiMeds review

A NAD injection listing that names Olympia and states 1,000 mg per vial.

We may earn a commission from partner links. Our reviews cover both partners and other providers. How we are funded

Where it fits

The named source is useful; the plan ladder needs a complete quote.

Reasons to consider it

  • Pharmacy source named
  • Vial amount stated

Worth a closer look

  • Starting rate not tied clearly to one term
  • FDA registration does not mean product approval

A named source

LumiMeds identifies Olympia and describes its source as a 503B pharmacy. The page states 1,000 mg per vial.

Those are useful details to have upfront, although a provider’s description alone is not independent proof of pharmacy or batch quality.

Three terms, one starting rate

The page shows monthly, three-month and six-month options alongside a $124 starting rate.

Ask which option qualifies and how much is charged immediately. The headline alone does not settle that.

Registration is not approval

The same page mentions FDA registration and states that compounded medication is not FDA-approved.

Keep those claims separate. Follow your prescription label rather than using a webpage’s general schedule as dosing advice.

What to ask before committing

Confirm the full amount due today, renewal terms, and any required consultation, laboratory, medication, supply or shipping fees. Check availability where you live and how you can reach support after signing up.

For prescription care, ask who will evaluate you and which pharmacy would dispense your medication. A provider comparison cannot determine whether a treatment is appropriate for you.

Put the details in context

Compare ingredients and formats Build a cost worksheet Read the research

This is an editorial assessment of published provider information, not a patient testimonial. Offers and availability can change. See our editorial standards.

Before you go

One more option to compare.

We may earn a commission from the partner below. It is a separate provider, and eligibility and treatment decisions require its own evaluation.

Explore partner Continue to your provider